Oxandrolone

氧雄龙

Report date: 2025/06/19 20:00:08
NME

Base Information

Drug NameOxandrolone
Drug Alias Name氧甲氢龙oxandrolonaoxandrolone羟甲睾酮oxandrolonum +[12] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionAndrogen Receptor agonists
TargetsAndrogen Receptor
Therapy Area/IndicationsWeight GainMalnutritionHypoplastic Left Heart Syndrome +[6] 
Global Approved IndicationsWeight Gain
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1964/07/21
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesGemini Labs Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUtah State UniversityCarelon ResearchGemini Labs Llc +[5] 
Active IndicationsN/A
Inactive IndicationsWeight GainMalnutritionHypoplastic Left Heart Syndrome +[6] 

Other Information

ATC CodeA14AA08
Related LinksWikipediaDrugBankKEGG